These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 315625)

  • 21. Proceedings: Fibrinogen degradation of normal and fibrinolytic plasma.
    Scully MF; Kakkar VV
    Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53894
    [No Abstract]   [Full Text] [Related]  

  • 22. Urokinase therapy: dose reduction by administration in plastic material.
    Zimmermann R; Schöffel G; Harenberg J
    Thromb Haemost; 1981 Jun; 45(3):296. PubMed ID: 7025343
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
    François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
    Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating system.
    Mattsson C; Nyberg-Arrhenius V; Wallén P
    Thromb Res; 1981 Mar; 21(6):535-45. PubMed ID: 7022741
    [No Abstract]   [Full Text] [Related]  

  • 27. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K; Takahashi A; Yoshimoto T
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
    Panchenko VM; Gilunova NI; Kozhomkulova BZh
    Lab Delo; 1977; (8):451-4. PubMed ID: 72846
    [No Abstract]   [Full Text] [Related]  

  • 29. [Urokinase in acute and chronic arterial diseases].
    Ciammaichella A; Gori M; Bonacci I
    Clin Ter; 1981 Nov; 99(4):377-81. PubMed ID: 7030591
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasma.
    Declerck PJ; Lijnen HR; Verstreken M; Collen D
    Thromb Haemost; 1991 Apr; 65(4):394-8. PubMed ID: 2057921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
    Sakuragawa N
    Nihon Naika Gakkai Zasshi; 1979 May; 68(5):486-9. PubMed ID: 469353
    [No Abstract]   [Full Text] [Related]  

  • 33. [Recurrent thrombosis of an aortic valve prosthesis in a pregnant woman. Treatment with urokinase].
    Jimenez M; Vergnes C; Brottier L; Dequeker JL; Billes MA; Lorient Roudaut MF; Choussat A; Boisseau MR
    J Mal Vasc; 1988; 13(1):46-9. PubMed ID: 3346615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of thrombolytic agents.
    Wolf P
    N Engl J Med; 1980 Apr; 302(14):812. PubMed ID: 6444451
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of thrombosis: anticoagulant-fibrinolytic therapy].
    Hasegawa H
    Nihon Rinsho; 1986 May; 44(5):1087-93. PubMed ID: 3528568
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombolytic therapy with urokinase. Clinical trials].
    Bizzi B; Leone G; Tutinelli F; Landolfi R
    Clin Ter; 1978 Sep; 86(5):419-32. PubMed ID: 737966
    [No Abstract]   [Full Text] [Related]  

  • 37. Urokinase or heparin in the management of patients with deep vein thrombosis?
    Kiil J; Carvalho A; Saksø P; Nielsen HO
    Acta Chir Scand; 1981; 147(7):529-32. PubMed ID: 7048826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin].
    Monastyrskiĭ VA; Ambarova LI
    Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
    Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of heparin, urokinase, and ancrod on intraglomerular coagulation induced in progressive Masugi nephritis.
    Dohi K; Fujioka M; Nakamoto Y
    Acta Pathol Jpn; 1982 Nov; 32(6):1047-52. PubMed ID: 6760667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.